Skip to main content

Month: April 2026

Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development

SOLANA BEACH, Calif., April 28, 2026 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological, or neurological conditions, today announced details of a strategic partnership with BioAI company ScienceMachine to accelerate the development of its fatty acid-binding protein 5 (FABP5) inhibitor platform. ScienceMachine’s platform, which leverages cutting-edge AI agent technology, is built to interrogate large biological datasets in a fraction of the time and cost of traditional methods. The partnership is harnessing ScienceMachine’s proprietary AI technology to analyze Artelo’s large internal FABP datasets and identify novel biological insights, including new mechanisms and...

Continue reading

Franklin Electric Reports First Quarter 2026 Results

First Quarter 2026 HighlightsConsolidated net sales of $500.4 million, an increase of 10% to the prior year Net sales increased across all three segments: 11% in Water Systems, 7% in Energy Systems, and 6% in Distribution Operating income was $48.1 million, an increase of 9% to the prior year, with operating margin of 9.6% GAAP fully diluted earnings per share (EPS) was $0.77, an increase of 15 percent; Adjusted diluted EPS was $0.831, an increase of 24 percentFORT WAYNE, Ind., April 28, 2026 (GLOBE NEWSWIRE) — Franklin Electric Co., Inc. today announced its first quarter financial results for fiscal year 2026. First quarter 2026 net sales were $500.4 million compared to first quarter 2025 net sales of $455.2 million. First quarter 2026 operating income was $48.1 million, compared to first quarter 2025 operating income of $44.1...

Continue reading

RELX Group enters into agreement to acquire French Legaltech company Doctrine

RELX Group is planning to acquire Doctrine, strengthening authoritative legal AI workflows in France and across Europe. Paris, France / New York, NY, April 28, 2026 (GLOBE NEWSWIRE) — RELX Group, which owns LexisNexis® Legal & Professional, a global leader in information, analytics, and AI-powered legal workflow solutions, today announced it has offered to acquire Doctrine, France-based Legal AI platform recognized for its advanced AI tools in legal search, analysis, drafting and practitioner workflows, including Flow Litigate and Flow Counsel. This proposed acquisition would accelerate the delivery of enhanced, trusted, intuitive and authoritative legal AI workflow solutions in France and across key European jurisdictions, including Germany, Spain and Italy and should assist customers to improve productivity and achieve better...

Continue reading

ExamWorks Announces Appointment of Isabelle Winkles as Chief Financial Officer to Support Continued Growth and Strategic Execution

ATLANTA, GA, April 28, 2026 (GLOBE NEWSWIRE) — ExamWorks Group (“ExamWorks”), a leading global provider of medical claims management solutions, including independent medical examinations, peer reviews, record retrieval and related risk management services, today announced the appointment of Isabelle Winkles as chief financial officer, effective June 1, 2026. Winkles brings extensive experience across strategic finance, capital markets, and global financial leadership. She joins ExamWorks from Braze, where she currently serves as chief financial officer and has played a central role in scaling the organization through its IPO and into its public company phase. In that role, she built and led a global finance organization and oversaw all aspects of financial operations, including financial planning and analysis, accounting, investor...

Continue reading

Turbo Energy Deploys AI-Driven Energy Storage Systems in International Military Operations, Expanding Into Mission-Critical Defense and Energy Security Applications

Active deployment in overseas military missions positions Turbo Energy at the forefront of mission-critical, off-grid energy infrastructure, advancing resilience and operational autonomy in defense environmentsTurbo Energy’s Sunbox Industry system deployed in a hybrid, off-grid solution for mission-critical operationsTurbo Energy’s Sunbox Industry system deployed in a hybrid, off-grid solution for mission-critical operationsTurbo Energy’s Sunbox Industry system deployed in a hybrid, off-grid solution for mission-critical operations VALENCIA, Spain, April 28, 2026 (GLOBE NEWSWIRE) — Turbo Energy, S.A. (Nasdaq: TURB) (“Turbo Energy” or the “Company”), a global integrator of AI-driven solar energy storage solutions and intelligent energy management systems, today announced the active deployment of its energy storage and...

Continue reading

Alm. Brand A/S – Supreme Court ruling on workers’ compensation leads to reserve strengthening and a profit warning for 2026

Today, the Danish Supreme Court ruled in favour of a 5% threshold for the degree of lost earnings capacity required for receiving compensation. This is lower than the 15% threshold applied by the Danish Labour Market Insurance to date. Alm. Brand Group has assessed the reserve strengthening required to reflect the new, lower threshold. In Q2 2026, the group will recognise a one-off charge of DKK 0.7 billion to strengthen reserves as a result of the Supreme Court ruling, which will affect the insurance service result. The guidance for the insurance service result in 2026 is thus lowered by DKK 0.7 billion to DKK 1.1-1.3 billion from DKK 1.8-2.0 billion previously. The guidance includes the one-off charge, which will be booked as a run-off loss in Q2 2026, but excludes other run-off gains or losses in Q2-Q4 2026. The expense ratio is expected...

Continue reading

ParaZero to Showcase DefendAir Counter-UAS Solutions at Three Major International Defense Exhibitions

Kfar Saba, Israel, April 28, 2026 (GLOBE NEWSWIRE) —  ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced its participation in three major international defense exhibitions in the coming weeks, where it will showcase its advanced DefendAir Counter-Unmanned Aerial Systems (C-UAS). The exhibitions include:Modern Day Marine (April 28-30, 2026, Washington, D.C.) – The premier event dedicated to the U.S. Marine Corps, focusing on expeditionary and littoral warfare capabilities. BSDA – Black Sea Defense & Aerospace (May 13-15, 2026, Bucharest, Romania) – The leading defense and aerospace exhibition in the Black Sea region, attracting NATO members and regional...

Continue reading

SEGG Media Exclusively Partners with Polymarket to Power Sports.com Predict

Integrates Polymarket’s leading prediction technology directly into Sports.com Predict. Enables a real-time, rapidly scalable sports prediction platform for SEGG Media ahead of the 2026 FIFA World Cup. Provides a robust technology framework to support a global rollout within established regulatory and operational frameworks. A transaction-based revenue share between SEGG Media and Polymarket creates a scalable, high-margin growth engine.FORT WORTH, Texas, April 28, 2026 (GLOBE NEWSWIRE) — Sports Entertainment Gaming Global Corporation (NASDAQ: SEGG, LTRYW) (the “Company” or “SEGG Media”) today announced that it entered into a strategic technology partnership and integration agreement with Polymarket to exclusively power Sports.com Predict, the Company’s prediction market platform on Sports.com. The partnership with Polymarket...

Continue reading

VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing

VivoSim’s NAMkind™ Intestinal Model combined with AI prediction tools yields high-accuracy results SAN DIEGO, April 28, 2026 (GLOBE NEWSWIRE) — VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced the availability of an AI prediction tool leveraging its NAMkind™ intestinal models to accurately predict the potential of a given drug compound to cause diarrhea in patients. The tool integrates its proprietary NAMkind™ ileum and colon tissues with advanced machine‑learning analytics to identify drug‑induced disruptions to intestinal epithelial integrity and function. Tissue-based assay data is used to train an AI predictive model in a process VivoSim has named VitroSense™. The model was built...

Continue reading

Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026

The Company will Host a Conference Call and Webcast on May 12, 2026, at 8:30 AM ET CORAL GABLES, Fla., April 28, 2026 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that it will release its first quarter 2026 financial results after the market close on Monday, May 11, 2026. Catalyst’s management team will host a conference call and webcast on Tuesday, May 12, 2026, at 8:30 AM ET to discuss the Company’s financial results and provide a business update.Conference Call & Webcast DetailsDate: May 12, 2026Time: 8:30 AM ETUS/Canada Dial-in Number: (855)...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.